NanoViricides, Inc. (NYSEMKT:NNVC)

CAPS Rating: 1 out of 5

Caps

How do you think NNVC will perform against the market?

Add Stock to CAPS Watchlist

All Players

29 Outperform
75 Underperform
 

All-Star Players

1 Outperform
45 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NNVC Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

kevin939516 (46.06)
Submitted March 01, 2011

Sole developer of technology that can be used to teat and/or prevent any viral infection. Yes, they are still in production of this technology, but they've had alot of promisingresearch lately. Additional bonus: it is not a vaccine so it will not… More

jed71 (99.85)
Submitted December 12, 2014

You can call me a skeptic all you want, but I just don’t trust reverse mergers that used to be internet retail companies, no matter how legitimate they try to make themselves in their recent past. I can’t help but feel their “pipeline” of 7 drug… More

NNVC VS S&P 500 (SPY)

Fools bullish on NNVC are also bullish on:

Fools bearish on NNVC are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NNVC.

Recs

0
Member Avatar john603 (72.90) Submitted: 12/30/2016 12:05:15 PM : Underperform Start Price: $1.13 NNVC Score: +24.68

Former internet. Now biotech Sure... Nevada. Reverse merger. Paid off on lawsuit demanding the books be opened. down thumb by 100 score favorite.

Recs

0
Member Avatar Colago77 (70.08) Submitted: 8/28/2015 10:53:33 AM : Underperform Start Price: $1.23 NNVC Score: +46.90

they cannot get product to clinical trails soon enough.

Recs

4
Member Avatar jed71 (99.85) Submitted: 12/12/2014 12:14:16 PM : Underperform Start Price: $2.81 NNVC Score: +90.54

You can call me a skeptic all you want, but I just don’t trust reverse mergers that used to be internet retail companies, no matter how legitimate they try to make themselves in their recent past. I can’t help but feel their “pipeline” of 7 drug candidates is about as valuable as a set of patents for manufacturing a buggy whip from the 1850’s. Here are the sections from the most recent 10-Q that convinced me to down thumb:

“NanoViricides, Inc. was incorporated under the laws of the State of Colorado on July 25, 2000 as Edot-com.com, Inc. which was organized for the purpose of conducting internet retail sales. On April 1, 2005, Edot-com.com, Inc. was incorporated under the laws of the State of Nevada for the purpose of re-domiciling as a Nevada corporation. On May 12, 2005, the corporations were merged and Edot-com.com, Inc., the Nevada corporation, became the surviving entity.”

“As a result of the Exchange transaction, the former NVI stockholders held approximately 80% of the voting capital stock of the Company immediately after the Exchange. For financial accounting purposes, this acquisition was a reverse acquisition of the Company by NVI, under the purchase method of accounting, and was treated as a recapitalization with NVI as the acquirer. Accordingly, the financial statements have been prepared to give retroactive effect to May 12, 2005 (date of inception), of the reverse acquisition completed on June 1, 2005, and represent the operations of NVI.”
“On February 15, 2010 the Company executed an Additional License Agreement with TheraCour Pharma, Inc. (“TheraCour”). Pursuant to the Additional License Agreement, the Company was granted exclusive licenses, in perpetuity, for technologies, developed by TheraCour, for the development of drug candidates for the treatment of Dengue viruses, Ebola/Marburg viruses, Japanese Encephalitis, viruses causing viral Conjunctivitis (a disease of the eye) and Ocular Herpes. As consideration for obtaining these exclusive licenses, we agreed to pay a onetime licensing fee equal to 2,000,000 shares (adjusted for the 3.5 to 1 reverse split) of the Company’s Series A Convertible Preferred Stock (the “Series A Preferred Stock”).”

“On or about April 13, 2012, the Nevada Agency and Transfer Company, as agent for service of process for the Company in Nevada, was served with a Summons and Complaint in the case entitled Yidam, Ltd. v. Eugene Seymour, Anil Diwan, and NanoViricides, Inc. (Case No. A-12-659535-B) answerable in the Eighth Judicial District Court of the State of Nevada – Clark County (“Court”). The Complaint seeks to compel inspection of the Company’s books and records. On or about May 2, 2012, the Company filed a Demand for Security of Costs.”

Zero revenue company with only some cash as assets. As of last count, about $41MM in cash. Take another look and that last cut and paste: a lawsuit to force the company to open its accounting books for inspection. I am not sure there’s a larger red flag than this. You have to go read the entire entry in the 10-Q, but essentially, they paid the plaintiffs $150K to make it go away. There is normally much more to the story when someone takes this kind of action. Couple this with the reverse merger and previous business plan and this seems to be another great red thumb. I would personally AVOID this firm.

Leaderboard

Find the members with the highest scoring picks in NNVC.

Score Leader

capostatus

capostatus (98.91) Score: +243.52

The Score Leader is the player with the highest score across all their picks in NNVC.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
uconn777 < 20 7/20/2010 Underperform 5Y $5.08 -80.13% +140.01% +220.14 0 Comment
longtermgrowth09 < 20 6/10/2010 Underperform 5Y $5.78 -82.51% +136.85% +219.36 0 Comment
Daxtonwin 99.83 9/7/2010 Underperform 5Y $3.78 -73.28% +131.47% +204.75 0 Comment
rodsoares 72.81 9/7/2010 Underperform 5Y $3.78 -73.28% +131.47% +204.75 0 Comment
SneakyPete21 < 20 9/7/2010 Underperform 5Y $3.78 -73.28% +131.47% +204.75 0 Comment
MATTEH 73.82 9/7/2010 Underperform 5Y $3.61 -71.98% +131.98% +203.97 0 Comment
HunterNumber9 73.17 11/17/2010 Underperform 5Y $5.62 -82.02% +116.12% +198.14 0 Comment
alexdowns77 96.46 9/28/2010 Underperform 5Y $3.61 -71.98% +123.27% +195.26 0 Comment
Griffinnoetfs 44.67 9/29/2010 Underperform 5Y $3.61 -71.98% +122.94% +194.93 0 Comment
walt393 99.90 8/18/2011 Underperform 5Y $4.06 -75.12% +119.29% +194.41 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackchardan 27.96 5/8/2014 Outperform NS $3.35 -69.85% +36.13% -105.98 0 Comment

Featured Broker Partners